Finance

Lists
GENIL:IST
Gen Ilac ve Saglik Urnlr Snyi ve Tcrt AS
TRY 4.39
-0.45%
(-0.020) 1D
Nov 11, 6:10:00 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for GENIL...
Open
TRY 4.41
High
TRY 4.53
Low
TRY 4.30
Mkt. cap
19.75B
Avg. vol.
91.94M
Volume
42.20M
Dividend
0.77%
Quarterly dividend
TRY 0.01
Ex-dividend date
Nov 12, 2025
P/E ratio
18.44
52-wk high
TRY 13.52
52-wk low
TRY 3.16
EPS
TRY 0.24
Shares outstanding
4.50B
No. of employees
690
Open
TRY 4.41
High
TRY 4.53
Low
TRY 4.30
Mkt. cap
19.75B
Avg. vol.
91.94M
Volume
42.20M
Dividend
0.77%
Quarterly dividend
TRY 0.01
Ex-dividend date
Nov 12, 2025
P/E ratio
18.44
52-wk high
TRY 13.52
52-wk low
TRY 3.16
EPS
TRY 0.24
Shares outstanding
4.50B
No. of employees
690
News stories
From web sources and news partners
About Gen Ilac ve Saglik Urnlr Snyi ve Tcrt AS
CEO-
Employees690
Founded1998
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitegenilac.com.tr
Previous reportsAll values in TRY
Loading Previous Earnings...
Revenue
Net income
All values in TRY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.82B
7.09B
7.75B
5.71B
Cost of goods sold
3.75B
5.00B
6.07B
3.83B
Cost of revenue
3.75B
5.00B
6.07B
3.83B
Research and development expenses
21.03M
23.90M
55.23M
19.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
843.92M
806.92M
746.24M
777.38M
Operating expense
790.82M
880.32M
802.17M
803.26M
Total operating expenses
4.54B
5.88B
6.87B
4.63B
Operating income
283.17M
1.20B
880.43M
1.07B
Other non operating income
-170.09M
-298.92M
47.83M
-365.33M
EBT including unusual items
545.00M
555.09M
355.94M
50.11M
EBT excluding unusual items
525.72M
757.78M
337.16M
51.03M
Income tax expense
396.92M
154.40M
-182.29M
-69.78M
Effective tax rate
72.83%
27.81%
-51.21%
-139.26%
Other operating expenses
-74.13M
49.51M
706.59K
6.31M
Net income
150.56M
401.45M
539.99M
120.73M
Net profit margin
3.12%
5.66%
6.97%
2.12%
Earnings per share
-
-
-
-
Interest and investment income
685.62M
94.64M
21.86M
87.21M
Interest expense
-269.26M
-258.79M
-597.61M
-608.40M
Net interest expenses
416.36M
-164.15M
-575.75M
-521.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
436.90M
1.34B
894.95M
1.41B
Gain or loss from assets sale
-4.70M
-262.52K
-25.12M
-1.74M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps